Showing results (51-60 of 58) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Brain Pathology (Zurich, Switzerland)|April 18, 1998
Frequent inactivation of CDKN2A and rare mutation of TP53 in PCNSLJ M Cobbers, M Wolter, J Reifenberger, et al.Oncogene|January 10, 2017
Analysis of DNA methylation in single circulating tumor cellsC F Pixberg, K Raba, F Müller, et al.Journal of Medical Genetics|November 11, 2008
Risk reducing mastectomy: outcomes in 10 European centresD G R Evans, A D Baildam, E Anderson, et al.British Journal of Cancer|June 9, 1999
European multicenter study on LOH of APOC3 at 11q23 in 766 breast cancer patients: relation to clinical variables. Breast Cancer Somatic Genetics ConsortiumV Launonen, K Laake, P Huusko, et al.Genes, Chromosomes & Cancer|June 24, 1999
Loss of heterozygosity at 11q23.1 and survival in breast cancer: results of a large European study. Breast Cancer Somatic Genetics ConsortiumK Laake, V Launonen, D Niederacher, et al.British Journal of Cancer|September 11, 2008
An evaluation of the polymorphisms Ins16bp and Arg72Pro in p53 as breast cancer risk modifiers in BRCA1 and BRCA2 mutation carriersA Osorio, M Pollán, G Pita, et al.British Journal of Cancer|June 7, 2012
Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter studyA Jakubowska, D Rozkrut, A Antoniou, et al.British Journal of Cancer|November 19, 2009
Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)A Osorio, R L Milne, G Pita, et al.Pageof 6